Cleared Traditional

K230751 - EW10-EC02 Endoscopy Support Program (FDA 510(k) Clearance)

Dec 2023
Decision
273d
Days
Class 2
Risk

K230751 is an FDA 510(k) clearance for the EW10-EC02 Endoscopy Support Program. This device is classified as a Gastrointesinal Lesion Software Detection System (Class II - Special Controls, product code QNP).

Submitted by Fujifilm Corporation (Ashigara Kami-Gun, JP). The FDA issued a Cleared decision on December 15, 2023, 273 days after receiving the submission on March 17, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1520. A Gastrointestinal Lesion Software Detection System Is A Computer-assisted Detection Device Used In Conjunction With Endoscopy For The Detection Of Abnormal Lesions In The Gastrointestinal Tract. This Device With Advanced Software Algorithms Brings Attention To Images To Aid In The Detection Of Lesions. The Device May Contain Hardware To Support Interfacing With An Endoscope..

Submission Details

510(k) Number K230751 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 2023
Decision Date December 15, 2023
Days to Decision 273 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code QNP — Gastrointesinal Lesion Software Detection System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1520
Definition A Gastrointestinal Lesion Software Detection System Is A Computer-assisted Detection Device Used In Conjunction With Endoscopy For The Detection Of Abnormal Lesions In The Gastrointestinal Tract. This Device With Advanced Software Algorithms Brings Attention To Images To Aid In The Detection Of Lesions. The Device May Contain Hardware To Support Interfacing With An Endoscope.